Circuit Event and Unfilled Demand
The stock of Venus Remedies Ltd reached its upper circuit price limit of Rs 866.25 on 24 Mar 2026, marking a 5.0% gain within the 5% price band allowed for the day. This ceiling effectively froze trading at the peak price, signalling that demand exceeded what the price band could accommodate. Buyers were willing to purchase shares at this elevated level, but sellers were absent, creating a scenario of unfilled demand. The total traded volume was 0.39749 lakh shares, with a turnover of Rs 3.35 crore, reflecting the mechanical suppression of volume typical on circuit days.
Delivery and Volume Analysis
Delivery volumes provide the clearest insight into the quality of this upper circuit move. On 23 Mar 2026, delivery volume stood at 34,200 shares, representing a 23.63% rise against the five-day average delivery volume. This increase suggests that a significant portion of traded shares was taken into investors' demat accounts, indicating genuine buying interest rather than intraday speculative trading. However, the weighted average price was closer to the day's low of Rs 819.20, implying that while the stock closed at the upper circuit, much of the volume was executed at lower price points during the session — a nuance that tempers the strength of the rally. Venus Remedies Ltd's delivery data is the most revealing metric on this circuit day — does the rising delivery volume confirm sustained conviction or is it a short-term spike?
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Moving Averages and Trend Context
Venus Remedies Ltd currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a well-established bullish trend. However, the stock remains below its 5-day moving average, indicating some short-term consolidation or resistance. The upper circuit day added further confirmation to the prevailing trend, as the price locked at the maximum allowed gain within the 5% band. This alignment of moving averages suggests that the rally is supported by technical strength rather than a mere speculative spike — how sustainable is this trend given the short-term moving average resistance?
Liquidity and Market Capitalisation Context
With a market capitalisation of approximately Rs 1,125 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest, with the stock liquid enough to support a trade size of around Rs 0.08 crore based on 2% of the five-day average traded value. This limited liquidity means that while the upper circuit is a strong momentum signal, the ability to enter or exit sizeable positions is constrained. Thin order books typical of micro-cap stocks can exaggerate price moves, and the circuit lock further restricts trading activity. Investors should be mindful of the liquidity risk inherent in such stocks, especially when demand outstrips supply at the circuit price.
Intraday Price Action
The intraday range for Venus Remedies Ltd was Rs 819.20 to Rs 866.25, a span of Rs 47.05. The stock touched its high at the circuit price and remained there, reflecting the price band's ceiling effect. The weighted average price skewed closer to the low end of the range, indicating that much of the volume was executed before the stock surged to the circuit. This pattern is common in circuit hits, where the rally accelerates late in the session, leaving some demand unfilled. The narrow trading band near the close underscores the mechanical nature of the circuit lock, which restricts further price discovery.
Fundamental Context
Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the micro-cap status limits broad institutional participation, the company’s fundamentals have supported a positive technical setup. The recent price action aligns with a sector gain of 1.32% and a Sensex increase of 2.33% on the same day, with Venus Remedies Ltd outperforming its sector by 3.65 percentage points.
Thinking about Venus Remedies Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this micro-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Conclusion: Circuit, Delivery, and Liquidity Signals
The upper circuit hit at Rs 866.25 capped a 5.0% gain for Venus Remedies Ltd, with delivery volumes rising 23.63% against the recent average. This combination points to a move supported by genuine buying interest rather than pure speculation. The stock’s position above key moving averages further reinforces the technical strength behind the rally. However, the micro-cap status and limited liquidity mean that the circuit lock also reflects the thin order book and constrained trade size. The circuit locked in gains but also locked out buyers who arrived late — should investors weigh the liquidity risk carefully before chasing this momentum?
